Metraipolis › archive › dc_fbc432712e79

Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After… — Europe PMC PMID:41140754

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41140754
DOI
10.1016/j.gastha.2025.100778
License (as archived)
solo-consultazione
Archived
2026-11-10T05:36:11.490Z
SHA-256 of the archived text
ed1c4c41c0935967a996371960ef5d62e7b4ec0e6f8f951500561e9cafa6d174
Stable URL of this page
https://metraipolis.com/documento/dc_fbc432712e79

How to cite

Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After… — Europe PMC PMID:41140754 — Europe PMC (en), https://europepmc.org/article/MED/41140754 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fbc432712e79 (Metraipolis archive dc_fbc432712e79, sha256 ed1c4c41c0935967a996371960ef5d62e7b4ec0e6f8f951500561e9cafa6d174)
BibTeX
@misc{dcfbc432712e79,
  title = {Vascular Endothelial Growth Factor Receptor 2-Targeted Therapy Suppresses the Progression of Alpha-Fetoprotein-Positive Hepatocellular Carcinoma After… — Europe PMC PMID:41140754},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41140754},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fbc432712e79; sha256 ed1c4c41c0935967a996371960ef5d62e7b4ec0e6f8f951500561e9cafa6d174},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41140754. Agents can read the archived copy with the MCP tool read_document.